ID   MK09_HUMAN              Reviewed;         382 AA.
AC   P45984-2;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 2.
DT   12-OCT-2022, entry version 224.
DE   RecName: Full=Isoform Alpha-1 of Mitogen-activated protein kinase 9;
DE            Short=MAP kinase 9;
DE            Short=MAPK 9;
DE            EC=2.7.11.24 {ECO:0000269|PubMed:11062067, ECO:0000269|PubMed:15805466, ECO:0000269|PubMed:17875713, ECO:0000269|PubMed:21110917, ECO:0000269|PubMed:7969172, ECO:0000269|PubMed:8001819, ECO:0000269|PubMed:8654373};
DE   AltName: Full=JNK-55;
DE   AltName: Full=Stress-activated protein kinase 1a;
DE            Short=SAPK1a;
DE   AltName: Full=Stress-activated protein kinase JNK2;
DE   AltName: Full=c-Jun N-terminal kinase 2;
GN   Name=MAPK9; Synonyms=JNK2, PRKM9, SAPK1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CATALYTIC ACTIVITY.
RX   PubMed=7969172; DOI=10.1128/mcb.14.12.8376-8384.1994;
RA   Sluss H.K., Barrett T., Derijard B., Davis R.J.;
RT   "Signal transduction by tumor necrosis factor mediated by JNK protein
RT   kinases.";
RL   Mol. Cell. Biol. 14:8376-8384(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CATALYTIC ACTIVITY.
RX   PubMed=8001819; DOI=10.1101/gad.8.24.2996;
RA   Kallunki T., Su B., Tsigelny I., Sluss H.K., Derijard B., Moore G.,
RA   Davis R., Karin M.;
RT   "JNK2 contains a specificity-determining region responsible for efficient
RT   c-Jun binding and phosphorylation.";
RL   Genes Dev. 8:2996-3007(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING, AND CATALYTIC ACTIVITY.
RC   TISSUE=Brain;
RX   PubMed=8654373; DOI=10.1002/j.1460-2075.1996.tb00636.x;
RA   Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B.,
RA   Davis R.J.;
RT   "Selective interaction of JNK protein kinase isoforms with transcription
RT   factors.";
RL   EMBO J. 15:2760-2770(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND CATALYTIC ACTIVITY.
RX   PubMed=21110917; DOI=10.5483/bmbrep.2010.43.11.738;
RA   Wang P., Xiong Y., Ma C., Shi T., Ma D.;
RT   "Molecular cloning and characterization of novel human JNK2 (MAPK9)
RT   transcript variants that show different stimulation activities on AP-1.";
RL   BMB Rep. 43:738-743(2010).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA-2).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-268.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-2).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y.,
RA   Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A.,
RA   Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y.,
RA   Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T.,
RA   Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y.,
RA   Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S.,
RA   Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in vitro-
RT   expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   INTERACTION WITH ATF7, AND FUNCTION.
RX   PubMed=10376527; DOI=10.1038/sj.onc.1202723;
RA   De Graeve F., Bahr A., Sabapathy K.T., Hauss C., Wagner E.F., Kedinger C.,
RA   Chatton B.;
RT   "Role of the ATFa/JNK2 complex in Jun activation.";
RL   Oncogene 18:3491-3500(1999).
RN   [13]
RP   PHOSPHORYLATION AT THR-183 AND TYR-185, REGULATION BY MAP2K4 AND MAP2K7,
RP   CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=11062067; DOI=10.1042/bj3520145;
RA   Fleming Y., Armstrong C.G., Morrice N., Paterson A., Goedert M., Cohen P.;
RT   "Synergistic activation of stress-activated protein kinase 1/c-Jun N-
RT   terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase
RT   kinase 4 (MKK4) and MKK7.";
RL   Biochem. J. 352:145-154(2000).
RN   [14]
RP   INTERACTION WITH SPAG9.
RX   PubMed=15693750; DOI=10.1042/bj20041577;
RA   Jagadish N., Rana R., Selvi R., Mishra D., Garg M., Yadav S., Herr J.C.,
RA   Okumura K., Hasegawa A., Koyama K., Suri A.;
RT   "Characterization of a novel human sperm-associated antigen 9 (SPAG9)
RT   having structural homology with c-Jun N-terminal kinase-interacting
RT   protein.";
RL   Biochem. J. 389:73-82(2005).
RN   [15]
RP   FUNCTION IN PHOSPHORYLATION OF RRN3, AND CATALYTIC ACTIVITY.
RX   PubMed=15805466; DOI=10.1101/gad.333205;
RA   Mayer C., Bierhoff H., Grummt I.;
RT   "The nucleolus as a stress sensor: JNK2 inactivates the transcription
RT   factor TIF-IA and down-regulates rRNA synthesis.";
RL   Genes Dev. 19:933-941(2005).
RN   [16]
RP   INTERACTION WITH NFATC4, AND CATALYTIC ACTIVITY.
RX   PubMed=17875713; DOI=10.1158/0008-5472.can-06-4788;
RA   Yao K., Cho Y.-Y., Bergen H.R. III, Madden B.J., Choi B.Y., Ma W.-Y.,
RA   Bode A.M., Dong Z.;
RT   "Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1
RT   induced cell transformation.";
RL   Cancer Res. 67:8725-8735(2007).
RN   [17]
RP   INTERACTION WITH BCL10, AND CATALYTIC ACTIVITY.
RX   PubMed=17189706; DOI=10.1016/j.immuni.2006.11.008;
RA   Blonska M., Pappu B.P., Matsumoto R., Li H., Su B., Wang D., Lin X.;
RT   "The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in
RT   the T cell receptor-signaling pathway.";
RL   Immunity 26:55-66(2007).
RN   [18]
RP   FUNCTION IN PHOSPHORYLATION OF TP53, AND CATALYTIC ACTIVITY.
RX   PubMed=17525747; DOI=10.1038/sj.onc.1210526;
RA   Oleinik N.V., Krupenko N.I., Krupenko S.A.;
RT   "Cooperation between JNK1 and JNK2 in activation of p53 apoptotic
RT   pathway.";
RL   Oncogene 26:7222-7230(2007).
RN   [19]
RP   REVIEW ON FUNCTION.
RX   PubMed=19290929; DOI=10.1111/j.1600-065x.2008.00749.x;
RA   Blonska M., Lin X.;
RT   "CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.";
RL   Immunol. Rev. 228:199-211(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CTNNB1.
RX   PubMed=19675674; DOI=10.1371/journal.pone.0006640;
RA   Hu D., Bi X., Fang W., Han A., Yang W.;
RT   "GSK3beta is involved in JNK2-mediated beta-catenin inhibition.";
RL   PLoS ONE 4:E6640-E6640(2009).
RN   [22]
RP   FUNCTION.
RX   PubMed=20595622; DOI=10.1152/ajpgi.00265.2010;
RA   Samak G., Suzuki T., Bhargava A., Rao R.K.;
RT   "c-Jun NH2-terminal kinase-2 mediates osmotic stress-induced tight junction
RT   disruption in the intestinal epithelium.";
RL   Am. J. Physiol. 299:G572-G584(2010).
RN   [23]
RP   FUNCTION IN PHOSPHORYLATION OF YAP1, AND CATALYTIC ACTIVITY.
RX   PubMed=21364637; DOI=10.1038/cddis.2010.7;
RA   Tomlinson V., Gudmundsdottir K., Luong P., Leung K.Y., Knebel A., Basu S.;
RT   "JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis.";
RL   Cell Death Dis. 1:E29-E29(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=22441692; DOI=10.1038/embor.2012.37;
RA   Yoshitane H., Honma S., Imamura K., Nakajima H., Nishide S.Y., Ono D.,
RA   Kiyota H., Shinozaki N., Matsuki H., Wada N., Doi H., Hamada T., Honma K.,
RA   Fukada Y.;
RT   "JNK regulates the photic response of the mammalian circadian clock.";
RL   EMBO Rep. 13:455-461(2012).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.14 ANGSTROMS) OF 7-362.
RX   PubMed=18801372; DOI=10.1016/j.jmb.2008.08.086;
RA   Shaw D., Wang S.M., Villasenor A.G., Tsing S., Walter D., Browner M.F.,
RA   Barnett J., Kuglstatter A.;
RT   "The crystal structure of JNK2 reveals conformational flexibility in the
RT   MAP kinase insert and indicates its involvement in the regulation of
RT   catalytic activity.";
RL   J. Mol. Biol. 383:885-893(2008).
RN   [27]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-13; ASN-56; THR-246 AND ILE-366.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [28]
RP   INTERACTION WITH MAPKBP1.
RX   PubMed=28089251; DOI=10.1016/j.ajhg.2016.12.011;
RA   Macia M.S., Halbritter J., Delous M., Bredrup C., Gutter A., Filhol E.,
RA   Mellgren A.E., Leh S., Bizet A., Braun D.A., Gee H.Y., Silbermann F.,
RA   Henry C., Krug P., Bole-Feysot C., Nitschke P., Joly D., Nicoud P.,
RA   Paget A., Haugland H., Brackmann D., Ahmet N., Sandford R., Cengiz N.,
RA   Knappskog P.M., Boman H., Linghu B., Yang F., Oakeley E.J.,
RA   Saint Mezard P., Sailer A.W., Johansson S., Roedahl E., Saunier S.,
RA   Hildebrandt F., Benmerah A.;
RT   "Mutations in MAPKBP1 cause juvenile or late-onset cilia-independent
RT   nephronophthisis.";
RL   Am. J. Hum. Genet. 100:323-333(2017).
RN   [29]
RP   ERRATUM OF PUBMED:28089251.
RX   PubMed=28157543; DOI=10.1016/j.ajhg.2017.01.025;
RA   Macia M.S., Halbritter J., Delous M., Bredrup C., Gutter A., Filhol E.,
RA   Mellgren A.E., Leh S., Bizet A., Braun D.A., Gee H.Y., Silbermann F.,
RA   Henry C., Krug P., Bole-Feysot C., Nitschke P., Joly D., Nicoud P.,
RA   Paget A., Haugland H., Brackmann D., Ahmet N., Sandford R., Cengiz N.,
RA   Knappskog P.M., Boman H., Linghu B., Yang F., Oakeley E.J.,
RA   Saint Mezard P., Sailer A.W., Johansson S., Roedahl E., Saunier S.,
RA   Hildebrandt F., Benmerah A.;
RL   Am. J. Hum. Genet. 100:372-372(2017).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=Alpha-2;
CC         IsoId=P45984-1; Sequence=Displayed;
CC       Name=Alpha-1;
CC         IsoId=P45984-2; Sequence=VSP_004835;
CC       Name=Beta-1;
CC         IsoId=P45984-3; Sequence=VSP_004834, VSP_004835;
CC       Name=Beta-2;
CC         IsoId=P45984-4; Sequence=VSP_004834;
CC       Name=5;
CC         IsoId=P45984-5; Sequence=VSP_041908, VSP_041909;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS43409.1; -.
DR   RefSeq; NP_620707.1; NM_139068.2.
DR   ProteomicsDB; 55699; -.
DR   Ensembl; ENST00000393360.7; ENSP00000377028.3; ENSG00000050748.18.
DR   Proteomes; UP000005640; Chromosome 5.
PE   1: Evidence at protein level;
SQ   SEQUENCE   382 AA;  44051 MW;  A1963C01247BDFF4 CRC64;
     MSDSKCDSQF YSVQVADSTF TVLKRYQQLK PIGSGAQGIV CAAFDTVLGI NVAVKKLSRP
     FQNQTHAKRA YRELVLLKCV NHKNIISLLN VFTPQKTLEE FQDVYLVMEL MDANLCQVIH
     MELDHERMSY LLYQMLCGIK HLHSAGIIHR DLKPSNIVVK SDCTLKILDF GLARTACTNF
     MMTPYVVTRY YRAPEVILGM GYKENVDIWS VGCIMGELVK GCVIFQGTDH IDQWNKVIEQ
     LGTPSAEFMK KLQPTVRNYV ENRPKYPGIK FEELFPDWIF PSESERDKIK TSQARDLLSK
     MLVIDPDKRI SVDEALRHPY ITVWYDPAEA EAPPPQIYDA QLEEREHAIE EWKELIYKEV
     MDWEERSKNG VVKDQPSAQM QQ
//
